Subscribe To
Swiss firm already sold leopard tanks destined for ukraine
The Swiss company Ruag wanted to sell the tanks to Germany, which intended to send them to Ukraine. But according to an investigation by the Tages-Anz...
August 27, 2023, 9:29 am
These four trends are shaping the gun industry
The gun industry is finding its footing after a post-pandemic sales slump forced some of the largest ma...
August 27, 2023, 8:00 am
Is it too late to buy eli lilly stock?
Eli Lilly continued to grow like a weed in the second quarter. The company's dividend payout ratio is somewhat low....
August 27, 2023, 7:20 am
Xeris biopharma's financial pathway: growth amid challenges
Xeris Biopharma reports notable revenue growth in Q2 2023 for its main products, Gvoke, Keveyis, and Recorlev. The company's expenses have also increa...
August 27, 2023, 1:30 am
Starbucks' pumpkin spice latte returns just in time for its 20th anniversary
Starbucks' (SBUX) pumpkin spice latte is returning for the fall season, marking the 20th anniversary of the beverage. Yahoo Finance Live reporters Bro...
August 26, 2023, 4:00 pm
These are the only 7 penny stocks to consider in august 2023
some of the most promising penny stocks can have multi-bagger potential over the long haul. After all, ...
August 26, 2023, 3:21 pm
Japanese yen forecast: usd/jpy, gbp/jpy establish and reinforce resistance
The Japanese Yen showed some resilience this past week after persistent weakness since the beginning of...
August 26, 2023, 1:14 pm
5 promising indicators pointing toward a bitcoin rally – what are the best coins to buy now?
Bitcoin’s price is struggling but there are plenty of signs that a rally could be imminent. In the meantime, we review ...
August 26, 2023, 12:44 pm
2 top ai stocks ready for a bull run
AI is taking tech stocks to new heights, but some potential giants are still undervalued. Despite impre...
August 26, 2023, 11:31 am
Usd/cad weekly outlook
USD/CAD’s rally from 1.3091 continued last week despite some interim retreat. Initial bias is now on ...
August 26, 2023, 9:39 am
International flavors & fragrances: a bad smell
International Flavors & Fragrances has been struggling since its acquisition of a big chunk of the DuPont business, with growth coming to a standstill...
August 26, 2023, 8:25 am
Profit potential: 5 undervalued stocks with high dividend yields
In some cases, it's even possible to offset losses elsewhere with dividends: A perfect example is the U...
August 26, 2023, 7:11 am
Bdc weekly review: will dividend coverage ever fall back to earth?
We take a look at the action in business development companies through the third week of August and highlight ...
August 26, 2023, 5:28 am
The weekly bottom line: fed chair powell sticks to tough talk
U.S. Highlights Speaking at the Jackson Hole Economic Symposium on Friday, Chair Powell noted that some ...
August 26, 2023, 2:52 am
Bitcoin miners celebrate us treasury’s new tax clarity
The U.S. Treasury Department has finally given some clarity – and perhaps a sigh of relief – to Bit...
August 25, 2023, 11:29 pm
Jpmorgan sees ‘limited downside’ for crypto near term after bitcoin’s recent rout
The recent selloff in crypto markets is likely near an end, with long-position liquidations “largely behind us,” according to a research report by...
August 25, 2023, 10:14 pm
Eur/jpy price analysis: advances and faces strong resistance at tenkan-sen, clings to 158.00
As the New York session closes, the Euro (EUR) recovers some ground against the Japanese Yen (JPY) afte...
August 25, 2023, 9:44 pm
Recent stock purchase august 2023
With August ending, and the markets still humming along relatively flat, I decided to add to some of my...
August 25, 2023, 8:25 pm
Ecb lagarde: need to set rates at sufficiently restrictive level for as long as necessary
Energy transition and climate change is triggering profound transformations in energy marketsWe are seeing profound changes in the labour market and t...
August 25, 2023, 7:05 pm
Neurocrine needs a meaningful clinical win to break out, and crinecerfont could do it
Neurocrine Biosciences needs a clinical win after years of disappointing results and stagnant stock performance. The upcoming Phase III data on crinec...
August 25, 2023, 6:01 pm